LEERINK CENTER FOR PHARMACOECONOMICS
LIVE

Serial Number

98876472

Owner

Leerink Intermediate Holdings LLC

Attorney

Cynthia J. Walden

First Use Date

Oct 22, 2024

Filing Date

Nov 27, 2024

Add to watchlist:

No watchlists yet
View on USPTO

LEERINK CENTER FOR PHARMACOECONOMICS Trademark

Serial Number: 98876472

LEERINK CENTER FOR PHARMACOECONOMICS is a trademark filed by Leerink Intermediate Holdings LLC on November 27, 2024. The trademark is classified under Class 9 (Computers & Electronics), Class 36 (Insurance & Financial), Class 41 (Education & Entertainment), Class 35 (Advertising & Business). The application is currently pending registration.

Owner Contact Info

Leerink Intermediate Holdings LLC

53 State Street
Boston, MA 02109

Entity Type: 16

Trademark Details

Filing Date

November 27, 2024

Registration Date

Not Registered

First Use Anywhere

October 22, 2024

First Use in Commerce

October 22, 2024

Published for Opposition

September 30, 2025

Goods & Services

Business consulting; Business advisory; Acquisition and merger consultation; Providing trade information; Compiling financial, securities, stock exchange, trade and quote, index value and other financial market information for business purposes; Business intermediary services relating to the matching of potential investors with corporations and entrepreneurs needing funding; Business consultation services, namely, business evaluation regarding firms in the biotechnology, pharmaceutical, and health fields for the assessment of the business value of medical and pharmaceutical innovation and technology

Downloadable reports, electronic newsletters and printable educational materials in the field of financial matters and business consulting in the biotechnology, pharmaceutical, and health fields for the assessment of the business and financial value of medical and pharmaceutical innovation and technology; Downloadable computer software for organizing and sharing commentary, resources, and evaluations related to business information, financial information, and consulting for the same; Downloadable computer software and downloadable mobile applications for use in investment banking management, accessing and conducting banking and financial business, and obtaining information, research, analysis, and advice in the fields of investments, banking, and financial services

Providing a website featuring online non-downloadable content in the nature of instructional videos, related to financial matters and business consulting in the biotechnology, pharmaceutical, and health fields for the assessment of the business and financial value of medical and pharmaceutical innovation and technology; Providing a website featuring online non-downloadable instructional videos, webinars and podcasts related to financial matters and business consulting in the biotechnology, pharmaceutical, and health fields for the assessment of the business and financial value of medical and pharmaceutical innovation and technology; Providing a website featuring online non-downloadable instructional videos, webinars and podcasts in the field of finance; Arranging and conducting conferences and events in the field of finance

Financial services, namely consulting and advising related to financial matters in the biotechnology, pharmaceutical, and health fields for the assessment of the financial value of medical and pharmaceutical innovation and technology; Providing information related to financial matters in the biotechnology, pharmaceutical, and health fields for the assessment of the financial value of medical and pharmaceutical innovation and technology; Financial consulting; Investment advisory and consulting services; Financial services, namely, investment advice, investment management, investment consultation; Information, advisory, consultancy and financial research services relating to finance and investments

Filing History

NOTIFICATION OF NON-FINAL ACTION E-MAILED
Aug 7, 2026 GNRN
NON-FINAL ACTION E-MAILED
Aug 7, 2026 GNRT
SU - NON-FINAL ACTION - WRITTEN
Aug 7, 2026 CNRT
STATEMENT OF USE PROCESSING COMPLETE
Jul 21, 2026 SUPC
USE AMENDMENT FILED
May 18, 2026 IUAF
TEAS STATEMENT OF USE RECEIVED
May 18, 2026 EISU
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 25, 2025 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 30, 2025 NPUB
PUBLISHED FOR OPPOSITION
Sep 30, 2025 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 24, 2025 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Sep 3, 2025 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Aug 25, 2025 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 25, 2025 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Aug 25, 2025 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
May 28, 2025 GNRN
NON-FINAL ACTION E-MAILED
May 28, 2025 GNRT
NON-FINAL ACTION WRITTEN
May 28, 2025 CNRT
ASSIGNED TO EXAMINER
May 20, 2025 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 15, 2025 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 15, 2025 NWOS
NEW APPLICATION ENTERED
Nov 27, 2024 NWAP